chr19-50252726-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001145809.2(MYH14):c.1918C>T(p.Arg640Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000203 in 1,595,570 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R640Q) has been classified as Likely benign.
Frequency
Consequence
NM_001145809.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH14 | NM_001145809.2 | c.1918C>T | p.Arg640Trp | missense_variant | 16/43 | ENST00000642316.2 | NP_001139281.1 | |
MYH14 | NM_001077186.2 | c.1918C>T | p.Arg640Trp | missense_variant | 16/42 | NP_001070654.1 | ||
MYH14 | NM_024729.4 | c.1894C>T | p.Arg632Trp | missense_variant | 15/41 | NP_079005.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH14 | ENST00000642316.2 | c.1918C>T | p.Arg640Trp | missense_variant | 16/43 | NM_001145809.2 | ENSP00000493594.1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000449 AC: 98AN: 218474Hom.: 1 AF XY: 0.000568 AC XY: 67AN XY: 117932
GnomAD4 exome AF: 0.000200 AC: 288AN: 1443290Hom.: 2 Cov.: 30 AF XY: 0.000242 AC XY: 173AN XY: 716216
GnomAD4 genome AF: 0.000236 AC: 36AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 01, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2020 | Has not been previously published as pathogenic or benign to our knowledge - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 03, 2018 | The p.Arg640Trp variant in MYH14 has been previously reported by our laboratory in 1 individual with hearing loss, and it has also been identified in 0.28% (75/ 26920) of South Asian chromosomes including 1 homozygote by the Genome Aggregati on Database (gnomAD, http://gnomad.broadinstitute.org). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Arg640Trp variant is uncertain. ACMG/AMP Criteria applied: BS1_Supporting. - |
MYH14-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 22, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at